Kisplyx 4 mg, Kapseln

7680660850011 CH-66085 Kapseln

Associated product:

KISPLYX caps 4 mg 30 pce
Kisplyx 4 mg, Kapseln
Kisplyx 4 mg, Kapseln
Kisplyx 4 mg, Kapseln
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/10/2025
Summary of Product Characteristics
Français
17/10/2025
Summary of Product Characteristics
Italien
17/10/2025
Patient information leaflet
Allemand
23/08/2025
Patient information leaflet
Français
23/08/2025
Patient information leaflet
Italien
23/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 1376.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2025

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
66085
Drug name
Kisplyx, Kapseln
Galenic form
KAHA
ATC Code
L01EX08
Authorization status
Z
Dispensing category
A
First authorization
25/08/2017
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Behandlung von fortgeschrittenem Nierenzellkarzinom (RCC)

Package details

Description (FR)
KISPLYX caps 4 mg 30 pce
Description (DE)
KISPLYX Kaps 4 mg 30 Stk
Market launch
25/08/2017
Narcotic (BTM)
No

Other package sizes (1)

KISPLYX caps 10 mg 30 pce
30 KAP
GTIN: 7680660850028
View